REGULATORY INTELLIGENCE·Recall
KENIL HEALTHCARE's Artridon Glucosamine Recalled Over CGMP Failures, Highlighting India Manufacturing Risks
KENIL HEALTHCARE PRIVATE LIMITED initiated a Class II recall (D-0421-2025) for 9,984 tubes of Artridon Glucosamine, a topical analgesic containing menthol and methyl salicylate, due to Current Good Manufacturing Practice (CGMP) deviations at its India facility. This terminated recall highlights persistent quality control risks in overseas manufacturing, necessitating rigorous supplier qualification and ongoing vigilance for procurement and regulatory teams sourcing similar active pharmaceutical ingredients and finished products.
90-Day Activity